Cargando…

Suboptimal prescribing of proton-pump inhibitors in low-dose aspirin users: a cohort study in primary care

OBJECTIVE: Determine the adherence to recommendations of concomitant proton-pump inhibitor (PPI) treatment in regular low-dose of aspirin (LDASA) users, taking factors associated with the probability of receiving a PPI into account. DESIGN: Cohort study. SETTING: Data were obtained from 120 Dutch pr...

Descripción completa

Detalles Bibliográficos
Autores principales: de Jong, Hilda J I, Korevaar, Joke C, van Dijk, Liset, Voogd, Eef, van Dijk, Christel E, van Oijen, Martijn G H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3731714/
https://www.ncbi.nlm.nih.gov/pubmed/23883887
http://dx.doi.org/10.1136/bmjopen-2013-003044
_version_ 1782279189828730880
author de Jong, Hilda J I
Korevaar, Joke C
van Dijk, Liset
Voogd, Eef
van Dijk, Christel E
van Oijen, Martijn G H
author_facet de Jong, Hilda J I
Korevaar, Joke C
van Dijk, Liset
Voogd, Eef
van Dijk, Christel E
van Oijen, Martijn G H
author_sort de Jong, Hilda J I
collection PubMed
description OBJECTIVE: Determine the adherence to recommendations of concomitant proton-pump inhibitor (PPI) treatment in regular low-dose of aspirin (LDASA) users, taking factors associated with the probability of receiving a PPI into account. DESIGN: Cohort study. SETTING: Data were obtained from 120 Dutch primary care centres participating in the Netherlands Information Network of Primary Care (LINH). PARTICIPANTS: Patients 18 years and older who were regularly prescribed LDASA (30–325 mg) in 2008–2010 were included. MAIN OUTCOME MEASURES: Regular medication use was defined as receiving each consecutive prescription within 6 months after the previous one. Based on national guidelines, we categorised LDASA users into low and high gastrointestinal (GI) risk. A multilevel multivariable logistic regression analysis was applied to identify patient characteristics that influenced on the probability of regular PPI prescriptions. RESULTS: We identified 12 343 patients who started LDASA treatment, of whom 3213 (26%) were at increased risk of GI complications. In this group, concomitant regular use of PPI was 46%, 36% did not receive PPI prescriptions and 18% obtained prescriptions irregularly (p<0.0001). The chance to obtain regularly PPI prescriptions versus no PPI was significantly influenced by, among others, previous GI complications (OR 13.9 (95% CI 11.8 to 16.4)), use of non-steroidal anti-inflammatory drugs (OR 5.2 (4.3 to 6.3)), glucocorticosteroids (6.1 (4.6 to 8.0)), selective serotonin reuptake inhibitors (9.1 (6.7 to 12.2)), drugs for functional GI disorders (2.4 (1.9 to 3.0)) and increased age. CONCLUSIONS: Primary care physicians do not fully adhere to the current recommendations to prescribe PPIs regularly to LDASA users with an increased GI risk. More than 50% of the patients with an increased GI risk are not treated sufficiently with a concomitant PPI, increasing the risk of GI side effects. This finding underlines the necessity to consider merging recommendations into one common, standard and frequently used recommendation by primary care physicians.
format Online
Article
Text
id pubmed-3731714
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-37317142013-08-02 Suboptimal prescribing of proton-pump inhibitors in low-dose aspirin users: a cohort study in primary care de Jong, Hilda J I Korevaar, Joke C van Dijk, Liset Voogd, Eef van Dijk, Christel E van Oijen, Martijn G H BMJ Open General practice / Family practice OBJECTIVE: Determine the adherence to recommendations of concomitant proton-pump inhibitor (PPI) treatment in regular low-dose of aspirin (LDASA) users, taking factors associated with the probability of receiving a PPI into account. DESIGN: Cohort study. SETTING: Data were obtained from 120 Dutch primary care centres participating in the Netherlands Information Network of Primary Care (LINH). PARTICIPANTS: Patients 18 years and older who were regularly prescribed LDASA (30–325 mg) in 2008–2010 were included. MAIN OUTCOME MEASURES: Regular medication use was defined as receiving each consecutive prescription within 6 months after the previous one. Based on national guidelines, we categorised LDASA users into low and high gastrointestinal (GI) risk. A multilevel multivariable logistic regression analysis was applied to identify patient characteristics that influenced on the probability of regular PPI prescriptions. RESULTS: We identified 12 343 patients who started LDASA treatment, of whom 3213 (26%) were at increased risk of GI complications. In this group, concomitant regular use of PPI was 46%, 36% did not receive PPI prescriptions and 18% obtained prescriptions irregularly (p<0.0001). The chance to obtain regularly PPI prescriptions versus no PPI was significantly influenced by, among others, previous GI complications (OR 13.9 (95% CI 11.8 to 16.4)), use of non-steroidal anti-inflammatory drugs (OR 5.2 (4.3 to 6.3)), glucocorticosteroids (6.1 (4.6 to 8.0)), selective serotonin reuptake inhibitors (9.1 (6.7 to 12.2)), drugs for functional GI disorders (2.4 (1.9 to 3.0)) and increased age. CONCLUSIONS: Primary care physicians do not fully adhere to the current recommendations to prescribe PPIs regularly to LDASA users with an increased GI risk. More than 50% of the patients with an increased GI risk are not treated sufficiently with a concomitant PPI, increasing the risk of GI side effects. This finding underlines the necessity to consider merging recommendations into one common, standard and frequently used recommendation by primary care physicians. BMJ Publishing Group 2013-07-23 /pmc/articles/PMC3731714/ /pubmed/23883887 http://dx.doi.org/10.1136/bmjopen-2013-003044 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/
spellingShingle General practice / Family practice
de Jong, Hilda J I
Korevaar, Joke C
van Dijk, Liset
Voogd, Eef
van Dijk, Christel E
van Oijen, Martijn G H
Suboptimal prescribing of proton-pump inhibitors in low-dose aspirin users: a cohort study in primary care
title Suboptimal prescribing of proton-pump inhibitors in low-dose aspirin users: a cohort study in primary care
title_full Suboptimal prescribing of proton-pump inhibitors in low-dose aspirin users: a cohort study in primary care
title_fullStr Suboptimal prescribing of proton-pump inhibitors in low-dose aspirin users: a cohort study in primary care
title_full_unstemmed Suboptimal prescribing of proton-pump inhibitors in low-dose aspirin users: a cohort study in primary care
title_short Suboptimal prescribing of proton-pump inhibitors in low-dose aspirin users: a cohort study in primary care
title_sort suboptimal prescribing of proton-pump inhibitors in low-dose aspirin users: a cohort study in primary care
topic General practice / Family practice
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3731714/
https://www.ncbi.nlm.nih.gov/pubmed/23883887
http://dx.doi.org/10.1136/bmjopen-2013-003044
work_keys_str_mv AT dejonghildaji suboptimalprescribingofprotonpumpinhibitorsinlowdoseaspirinusersacohortstudyinprimarycare
AT korevaarjokec suboptimalprescribingofprotonpumpinhibitorsinlowdoseaspirinusersacohortstudyinprimarycare
AT vandijkliset suboptimalprescribingofprotonpumpinhibitorsinlowdoseaspirinusersacohortstudyinprimarycare
AT voogdeef suboptimalprescribingofprotonpumpinhibitorsinlowdoseaspirinusersacohortstudyinprimarycare
AT vandijkchristele suboptimalprescribingofprotonpumpinhibitorsinlowdoseaspirinusersacohortstudyinprimarycare
AT vanoijenmartijngh suboptimalprescribingofprotonpumpinhibitorsinlowdoseaspirinusersacohortstudyinprimarycare